Page last updated: 2024-09-02

opc 21268 and l 371257

opc 21268 has been researched along with l 371257 in 2 studies

Compound Research Comparison

Studies
(opc 21268)
Trials
(opc 21268)
Recent Studies (post-2010)
(opc 21268)
Studies
(l 371257)
Trials
(l 371257)
Recent Studies (post-2010) (l 371257)
133362308

Protein Interaction Comparison

ProteinTaxonomyopc 21268 (IC50)l 371257 (IC50)
Oxytocin receptorRattus norvegicus (Norway rat)0.64

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clineschmidt, BV; Erb, JM; Freidinger, RM; Guidotti, MT; Lis, EV; Pawluczyk, JM; Pettibone, DJ; Reiss, DR; Veber, DF; Williams, PD1
Borthwick, AD1

Other Studies

2 other study(ies) available for opc 21268 and l 371257

ArticleYear
1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist.
    Journal of medicinal chemistry, 1995, Nov-10, Volume: 38, Issue:23

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzoxazines; Biological Availability; Female; Humans; Kinetics; Molecular Structure; Obstetric Labor, Premature; Oxazines; Oxytocin; Piperidines; Pregnancy; Rats; Receptors, Oxytocin; Receptors, Vasopressin; Uterine Contraction

1995
Oral oxytocin antagonists.
    Journal of medicinal chemistry, 2010, Sep-23, Volume: 53, Issue:18

    Topics: Administration, Oral; Animals; Biological Availability; Camphor; Humans; Indoles; Oxytocin; Piperazines; Piperidines; Protein Conformation; Pyrrolidines; Receptors, Oxytocin; Sulfonamides; Triazoles

2010